tm logo
CANNRX
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 29 Sep 2015

Last Applicant/ Owned by

5 Columbus Circle - 8th Floor

New York

NY

10019

Serial Number

86312885 filed on 18th Jun 2014

Registration Number

N/A

Correspondent Address

JOEL N. BOCK

DENTONS US LLP

PO BOX 61080

CHICAGO, IL 60606-1080

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CANNRX

The mark consists of the letters "CANNRX", of which the tail of the letter "C" extends horizontally under the remaining letters. Laboratory apparatus and instruments for use in extracting, purifying and concentrating marijuana, cannabis, hemp for use in developing medical, pharmaceutical and recreational products Pharmaceutical products, namely, pills, powders, tinctures, liquids, mists, vapors,Read More

Classification Information


Class [001]
Chemical Products


Biological assays for use in scientific research; biological assays for use in antibody based identification methods; kits comprising biological assays and reagents, marking agents, chemicals, test tubes, syringes for laboratory research use; kits comprising chemicals, reagents, marking agents, test tubes, syringes for use in developing pharmaceutical products

Class [005]
Pharmaceutical Products


Pharmaceutical products, namely, pills, powders, tinctures, liquids, mists, vapors, capsules, preparations, ointments, creams for use in treating pain, nausea, seizures, appetite disorders, dementia, psychiatric disorders, insomnia, Krohn's disease, headache, migraines, multiple sclerosis, Parkinson's, PTSD, anorexia, cancer

Class [009]
Computer & Software Products & Electrical & Scientific Products


Laboratory apparatus and instruments for use in extracting, purifying and concentrating marijuana, cannabis, hemp for use in developing medical, pharmaceutical and recreational products

Class [042]
Computer & Software Services & Scientific Services


Development of research models for designing, testing and developing medical, pharmaceutical and recreational products, namely, medical marijuana, pain relief medications, cancer treatment drugs, medications for relieving nausea, medications for treating seizures, appetite disorders, dementia, psychiatric disorders, insomnia, Krohn's disease, headache, migraines, multiple sclerosis, Parkinson's, PTSD, anorexia; Consulting and laboratory services relating to testing of medical, recreational and pharmaceutical products namely, medical marijuana, pain relief medications, cancer treatment drugs, medications for relieving nausea, medications for treating seizures, appetite disorders, dementia, psychiatric disorders, insomnia, Krohn's disease, headache, migraines, multiple sclerosis, Parkinson's, PTSD, anorexia; Analysis in the nature of scientific and medical research relating to the components of natural extracts, oils, seeds, plant matter for pharmaceutical activity, byproducts, contaminants, impurities, and for use in the treatment of various diseases and medical conditions

Mark Details


Serial Number

No 86312885

Mark Type

No Service Mark

Attorney Docket Number

No 20007521-000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.13 -

Letters or words underlined and/or overlined by one or more strokes or lines

Description of Design Search

The mark consists of the letters "CANNRX", of which the tail of the letter "C" extends horizontally under the remaining letters.

Legal History


Show more

Status DateAction Taken
30th Sep 2015ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
29th Sep 2015ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
26th Feb 2015NON-FINAL ACTION E-MAILED
26th Feb 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
26th Feb 2015NON-FINAL ACTION WRITTEN
27th Jan 2015TEAS/EMAIL CORRESPONDENCE ENTERED
27th Jan 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
20th Jan 2015ASSIGNED TO LIE
12th Jan 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
09th Oct 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED